Recovery Unplugged Fort Lauderdale is proud to announce the addition of Spravato® (esketamine) therapy to its comprehensive ...

Apimostinel has a similar mode of action to ketamine and derivatives like Johnson & Johnson's Spravato (esketamine) – ...

Although the FDA has approved ketamine for use as an anesthetic, infusion therapy hasn't been approved to treat chronic pain, depression, or other conditions.

Nasal congestion happens when passages in the nasal cavity are blocked. 1 When nasal passages are blocked, nasal breathing can be more challenging, meaning it is harder to breathe through the nose ...

The psychedelic drugs market was valued at $0.7 billion in 2022 and is projected to reach $2.6 billion by 2032, growing at a CAGR of 13.4% from 2023 to 2032.

“We are pleased with the steady progress we are making with our proposed ketamine implants, which are being uniquely designed with a goal of providing sustained relief of chronic pain.” Preclinical ...

The Company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic ...

Background: Intranasal administration is a convenient route for drug delivery that can be applied for procedural sedation. However, there is currently limited exploration into fixed dosing regimens.

However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button. Objectives: Intravenous ketamine (IVK) and intranasal esketamine (ESK) are increasingly used in ...

“As polysubstance use and use of ketamine for treatment-resistant depression and in compounded formulations increase, continued monitoring is needed to identify potential changes in the ...